Bradley Wiggins will respond to 'unethical' doping claim

The Digital, Culture, Media and Sport (DCMS) committee’s report, published yesterday, accused the 2012 Tour de France winner and other Team Sky riders of using the drug triamcinolone not for the stated purpose of treating asthma but because it helped them lose weight without compromising power.
It was revealed in 2015 by Russian computer hackers that Wiggins had applied for therapeutic use exemptions (TUEs) to have injections of the powerful corticosteroid before three of his biggest races, including the 2012 Tour.